Neuroendocrinologic Findings in Patients With Untreated Huntington's Chorea
- 1 May 1984
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 41 (5) , 516-520
- https://doi.org/10.1001/archneur.1984.04050170062019
Abstract
• Huntington's chorea (HC) was studied in 14 untreated patients, in six patients receiving long-term neuroleptic treatment, and in four patients after drug withdrawal. Our results showed that patients with HC may be divided into three groups, otherwise clinically indistinguishable, on the basis of growth hormone responsiveness to dopaminergic stimuli. The existence of subpopulations of patients with HC must be considered in further studies on these subjects.This publication has 14 references indexed in Scilit:
- Neuroendocrine Control of Thyrotropin SecretionEndocrine Reviews, 1981
- Growth Hormone-Releasing Effect of an Enkephalin Analog in the Dog: Evidence for Cholinergic Mediation*Endocrinology, 1980
- Growth hormone and prolactin secretion in Huntington's diseaseLife Sciences, 1979
- The Control of Somatotropin SecretionPublished by Elsevier ,1979
- Neuroendocrine function in Huntington's disease: Dopaminergic regulation of prolactin releaseLife Sciences, 1978
- Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studiesBrain Research, 1977
- IMPAIRED PROLACTIN RELEASE IN HUNTINGTON'S CHOREAThe Lancet, 1977
- Altered Growth Hormone and Prolactin Responses to Dopaminergic Stimulation in Huntington's ChoreaJournal of Clinical Endocrinology & Metabolism, 1977
- Bromocriptine in Huntington ChoreaArchives of Neurology, 1976
- Plasma Growth Hormone Concentrations in Huntington's ChoreaClinical Science, 1976